» Abstracts
Short Talk abstracts:
Talk abstract submission deadline: August 25, 2026
Poster abstracts:
Poster abstract submission deadline: September 10, 2026
Abstract Submission Guidelines
Title: Short and informative, sentence case, bold, justified text
Author and Affiliations: Include first and last names of all authors. Presenting author names must be in bold. Use superscript numbers to indicate affiliation(s) and include city, state, and country details.
Abstract: Provide a short (250 words) abstract that may include details on background, aims, methods, results, and conclusion.
Call for Abstracts
Researchers, clinicians, students and industry professionals are invited to submit abstracts presenting original research, emerging technologies and developments across oligonucleotide and RNA therapeutics.
Abstract Topics
• Antisense Oligonucleotides
• siRNA and Gene Silencing
• mRNA Therapeutics
• microRNA Biology and Therapeutics
• Ribozymes and Catalytic RNA
• CRISPR and Gene Editing
• RNA Delivery Technologies
• Oligonucleotide Chemistry and Manufacturing
• Preclinical and Clinical Development
• Emerging RNA Technologies